Biological variation and reference change value (RCV) of prostate specific antigen (PSA) levels in the serum of healthy young individuals

Gazi Medical Journal

Volumn 20, Issue 4, 2009, Pages 152-156

  Erden, Gönül ^a   Tezcan, Günay ^a   Soydas, Özden Ayse ^a   Yildirimkaya, Metin Mustafa ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Biological variability; Total PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; ANALYZER; ANTIGEN SPECIFICITY; ARTICLE; BLOOD SAMPLING; CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY; CHEMOLUMINESCENCE; HUMAN; INTRASPECIFIC VARIATION; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; NORMAL HUMAN; PROSTATE SPECIFIC ANTIGEN BLOOD LEVEL; PROTEIN BLOOD LEVEL; RANDOM ACCESS ANALYZER; REFERENCE VALUE;

EID: 77951527055     PISSN: 1300056X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ilic D, O'Connoe D, Green S, Wilt T. Screening for prostate cancer. Cochrane Database of Systematic Reviews 2006, Issue 3.Art. No.:CD004720.DOI: 10.1002/14651858.CD004720.pub2.
2. Lobel B. Screening for prostate cancer - how to manage in 2006? Acta Chir Iugosl 2005; 52: 19-21.
3. Boyle P, Severi G, Giles GG. The epidemiology of prostate cancer. Urol Clin North Am 2003; 30: 209-217.
4. Oliver SE, May MT, Gunnell D. International trends in prostate-cancer mortality in the PSA era. Int J Cancer 2001; 92: 893-898.
5. Piironen T, Pettersson K, Suonpaa M, et al. In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen complexed to alpha 1-antichymotrypsin in blood samples. Urol 1996; 48: 81-87.
6. Yan Y. Intra-individual variation of prostate specific antigen measurement and implications for early detection of prostate carcinoma. Cancer 2001; 92: 776-780.
7. Fraser CG. Changes in serial results. The nature of biological variation. In: Fraser CG, ed. Biological variation: from principles to practice. Washington, DC: AACC Press, 2001: 67-90.
8. Stenman UH, Leinonen J, Zhang WM, Finne P, Wu P. The clinical importance of free prostate specific antigen. Curr Opin Urol 1998; 8: 393-399. (Pubitemid 28479232)
9. Soletormos G, Semjonow A, Sibley PEC, et al. on behalf of the European Group on Tumor Markers. Biological variation of total prostate specific antigen: A survey of published estimates and consequences for clinical practice. Clinical Chem 2005; 51: 1342-1351.
10. Hyltoft P, Fraser CG, Jorgensen L, Brandslund I, Stahl M et al. Combination of analytical quality specifications based on biological within- and between-subject variation. Ann Clin Biochem 2002; 39: 543-550. (Pubitemid 35316286)
11. Nixon RG, Wener MH, Smith KM, et al. Biological variation of prostate specific antigen levels in serum: An evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients. J Urol 1997; 157: 2183-2190.
12. Glenski WJ, Klee GG, Bergstralh EJ, Oesterling JE. Prostate-specific antigen: establishment of the reference range for the clinically normal prostate gland and the effect of digital rectal examination, ejaculation and the time on serum concentrations. Prostate 1992; 21: 99-110.
13. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989; 27: 409-437.
14. Ornstein DK, Smith DS, Rao GS, Basier JW, Ratliff TL, Catalona WJ. Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers. J Urol 1997; 157: 2179-2182. (Pubitemid 27208667)
15. Talwar DK, Azharuddin MK, Williamson C, Teoh YP, McMillan DC, O'Reilly DSJ. Biological variation of vitamins in blood of healthy individuals. Clin Chem 2005; 51: 2145-2150.
16. Yildirimkaya MM, Bilgi C, Ozata M, et al. Biological variation of serum lipids and lipoproteins in patients with clinically well controlled non insulin dependent Diabetes Mellitus. Endocrine J 1996; 43: 345-351. (Pubitemid 126527654)
17. Boddy JL, Dev S, Pike DJ, Malone PR. Intra-individual variation of serum prostate specific antigen levels in men with benign prostate biopsies. BJU International 2004; 93: 735-738. (Pubitemid 38497020)
18. Brunn L, Becker C, Hugosson J, Lilja H, Christenson A. Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden. Prostate 2005; 65: 216-221. (Pubitemid 41443726)
19. Price CP, Allard J, Davies G, et al. Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer. Ann Clin Biochem 2001; 38: 188-216. (Pubitemid 32430000)
20. Morote J, Raventos CX, Lorente JA, et al. Intra-individual variations of total and percent free serum prostatic-specific antigen levels in patients with digital rectal examination. Eur Urol 1999; 36: 111-115. (Pubitemid 29348798)
21. Prestigiacomo AF, Stamey TA. Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng/mL range in male volunteers. J Urol 1996; 155: 1977-1980.
22. Browning MCK, McFarlane NP. Objective interpretation of results for tumour markers. J Nucl Med Allied Sci 1990; 34: 89-91.
23. Bunting PS, DeBoer G, Choo R, Danjoux C, Klotz L, Fleshner N. Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation. Clin Biochem 2002; 35: 471-475. (Pubitemid 35284544)